{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:19:39Z","timestamp":1786371579306,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.jcrs.2004.05.019","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T10:23:46Z","timestamp":1092479026000},"page":"1653-1660","source":"Crossref","is-referenced-by-count":51,"title":["Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients"],"prefix":"10.1097","volume":"30","author":[{"given":"Kerry D","family":"Solomon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D","family":"Donnenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Raizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga P","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"VanDenburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-26-20210210","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0886-3350(00)00832-4","article-title":"Comparison of ketorolac tromethamine 0.5 and rimexolone 1 to control inflammation after cataract extraction; prospective randomized double-masked study.","volume":"27","author":"Solomon","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"R3-26-20210210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0886-3350(13)80208-8","article-title":"Corneal subepithelial infiltrates following excimer laser photorefractive keratectomy.","volume":"21","author":"Teal","year":"1995","journal-title":"J Cataract Refract Surg"},{"key":"R4-26-20210210","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0161-6420(00)00538-8","article-title":"Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.","volume":"108","author":"Guidera","year":"2001","journal-title":"Ophthalmology"},{"key":"R5-26-20210210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9394(98)00413-9","article-title":"Ketorolac tromethamine 0.5 ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.","volume":"127","author":"Heier","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R6-26-20210210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0886-3350(01)01185-3","article-title":"Comparison of ketorolac tromethamine 0.5 and loteprednol etabonate 0.5 for inflammation after phacoemulsification; prospective randomized double-masked study.","volume":"28","author":"Holzer","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R7-26-20210210","first-page":"661","article-title":"Analgesic efficacy and safety of ketorolac after photorefractive keratectomy; the Ketorolac Study Group.","volume":"15","author":"Rajpal","year":"1999","journal-title":"J Refract Surg"},{"key":"R10-26-20210210","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0886-3350(01)00801-X","article-title":"Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs.","volume":"27","author":"Congdon","year":"2001","journal-title":"J Cataract Refract Surg"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335004005541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335004005541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.jcrs.2004.05.019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:26:46Z","timestamp":1785785206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02158034-200408000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2004.05.019","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}